Literature DB >> 16164883

Obesity as a risk factor in venous thromboembolism.

Paul D Stein1, Afzal Beemath, Ronald E Olson.   

Abstract

PURPOSE: Whether obesity is an independent risk factor for pulmonary embolism or deep venous thrombosis has not been fully determined.
METHODS: We used the database of the National Hospital Discharge Survey to further investigate the potential risk of obesity in venous thromboembolic disease.
RESULTS: The relative risk of deep venous thrombosis, comparing obese patients with non-obese patients, was 2.50 (95% confidence interval [CI] = 2.49-2.51). The relative risk of pulmonary embolism was 2.21 (95% CI = 2.20-2.23). Obese females had a greater relative risk for deep venous thrombosis than obese males, 2.75 (95% CI = 2.74-2.76) versus 2.02 (95% CI = 2.01-2.04). Obesity had the greatest impact on both men and women aged less than 40 years.
CONCLUSION: The data indicate that obesity is a risk factor for venous thromboembolic disease in men as well as women.

Entities:  

Mesh:

Year:  2005        PMID: 16164883     DOI: 10.1016/j.amjmed.2005.03.012

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  124 in total

1.  Anti-Xa Levels 4 h After Subcutaneous Administration of 5,700 IU Nadroparin Strongly Correlate with Lean Body Weight in Morbidly Obese Patients.

Authors:  Jeroen Diepstraten; Christian M Hackeng; Simone van Kralingen; Jiri Zapletal; Eric P A van Dongen; René J Wiezer; Bert van Ramshorst; Catherijne A J Knibbe
Journal:  Obes Surg       Date:  2012-02-01       Impact factor: 4.129

Review 2.  Predicting the risk of recurrent venous thromboembolism (VTE).

Authors:  Michael B Streiff
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

3.  Obesity is associated with postinjury hypercoagulability.

Authors:  Jason M Samuels; Ernest E Moore; Julia R Coleman; Joshua J Sumislawski; Mitchell J Cohen; Christopher C Silliman; Anirban Banerjee; Arsen Ghasabyan; James Chandler; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-10       Impact factor: 3.313

4.  Activated partial thromboplastin time and risk of future venous thromboembolism.

Authors:  Neil A Zakai; Tetsuya Ohira; Richard White; Aaron R Folsom; Mary Cushman
Journal:  Am J Med       Date:  2008-03       Impact factor: 4.965

Review 5.  [Physical prophylaxis for thromboembolism. Current state of knowledge on use of medical thromboprophylaxis stockings].

Authors:  P Kujath; M Hoffmann
Journal:  Chirurg       Date:  2013-12       Impact factor: 0.955

6.  Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study.

Authors:  Aneel A Ashrani; Rachel E Gullerud; Tanya M Petterson; Randolph S Marks; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2016-01-05       Impact factor: 3.944

7.  Early-onset obesity and the unwanted promise of thrombosis.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

8.  Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary Disease.

Authors:  Victor Kim; Nishant Goel; Jinal Gangar; Huaqing Zhao; David E Ciccolella; Edwin K Silverman; James D Crapo; Gerard J Criner
Journal:  Chronic Obstr Pulm Dis       Date:  2014

9.  Can venous thromboembolism navigate the prevention of cardiovascular complications?

Authors:  Alena Shantsila; Gregory Y H Lip
Journal:  Ann Transl Med       Date:  2015-06

Review 10.  Inflammation, obesity, and thrombosis.

Authors:  Fahumiya Samad; Wolfram Ruf
Journal:  Blood       Date:  2013-10-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.